AbbVie (ABBV) Interest & Investment Income (2012 - 2016)

AbbVie (ABBV) has reported Interest & Investment Income for 5 consecutive years, with $20.0 million the latest figure, recorded in Q2 2016.

• In Q2 2016, Interest & Investment Income rose 150.0% year-over-year to $20.0 million; the TTM figure through Jun 2016 stood at $54.0 million (up 22.73% YoY), while the FY2015 annual figure was $33.0 million, down 13.16% from the prior year.
• Interest & Investment Income improved to $20.0 million in Q2 2016 per ABBV's latest filing, from $15.0 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $20.0 million in Q3 2014 and bottomed at $1.0 million in Q1 2012.
• Historically, Interest & Investment Income has averaged $8.3 million across 5 years, with a median of $6.0 million in 2012.
• Annual changes were most pronounced in 2013 — Interest & Investment Income surged 500.0% — and 2015, when it plunged 50.0%.
• AbbVie's Interest & Investment Income stood at $6.0 million in 2012, then changed by 0.0% to $6.0 million in 2013, then soared by 66.67% to $10.0 million in 2014, then declined by 10.0% to $9.0 million in 2015, then soared by 122.22% to $20.0 million in 2016.
• Business Quant data shows ABBV's Interest & Investment Income at $20.0 million in Q2 2016, $15.0 million in Q1 2016, and $9.0 million in Q4 2015.